Literature DB >> 20835809

[Dermal necrosis as cutaneous manifestation of heparin-induced thrombocytopenia II?].

M Illes1, S Klaus, J C Simon, R Treudler.   

Abstract

Most of the rare cases of skin necrosis following heparin injections are associated with the immunologically mediated form of heparin-induced thrombocytopenia II (HIT II). We present a 62-year- old woman who developed a necrotic abdominal lesion seven days after starting daily subcutaneous injections of the low molecular heparin enoxaparin. We detected circulating antibodies against the platelet factor 4-complex but no concomitant thrombocytopenia. An isolated, antibody-mediated thrombosis of dermal vessels is the likely underlying cause of the skin necrosis in HIT II.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20835809     DOI: 10.1007/s00105-010-1999-3

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  10 in total

Review 1.  [Heparin-induced thrombocytopenia].

Authors:  K Gürtler; I Euchner-Wamser; G Neeser
Journal:  Anaesthesist       Date:  2006-09       Impact factor: 1.041

2.  Heparin-induced thrombocytopenia: overview and treatment.

Authors:  Daniel A Zinkovsky; Marilena S Antonopoulos
Journal:  P T       Date:  2008-11

Review 3.  Adverse skin reactions to low molecular weight heparins: frequency, management and prevention.

Authors:  R Wütschert; P Piletta; H Bounameaux
Journal:  Drug Saf       Date:  1999-06       Impact factor: 5.606

Review 4.  Allergy to heparins and anticoagulants with a similar pharmacological profile: an update.

Authors:  Uta Jappe
Journal:  Blood Coagul Fibrinolysis       Date:  2006-11       Impact factor: 1.276

5.  Tolerance to intravenous administration of heparin and heparinoid in a patient with delayed-type hypersensitivity to heparins and heparinoids.

Authors:  W H Boehncke; L Weber; H Gall
Journal:  Contact Dermatitis       Date:  1996-08       Impact factor: 6.600

Review 6.  Low molecular weight heparin-induced skin necrosis-a systematic review.

Authors:  A E Handschin; O Trentz; H J Kock; G A Wanner
Journal:  Langenbecks Arch Surg       Date:  2004-11-27       Impact factor: 3.445

Review 7.  Hypersensitivity reactions to anticoagulant drugs: diagnosis and management options.

Authors:  A J Bircher; T Harr; L Hohenstein; D A Tsakiris
Journal:  Allergy       Date:  2006-12       Impact factor: 13.146

8.  Low molecular weight heparin-induced skin necrosis occurring distant from injection sites and without thrombocytopenia.

Authors:  U J Tietge; H H Schmidt; E Jäckel; C Trautwein; M P Manns
Journal:  J Intern Med       Date:  1998-04       Impact factor: 8.989

Review 9.  Contemporary standards for the diagnosis and treatment of heparin-induced thrombocytopenia (HIT).

Authors:  Zachary K Baldwin; Austin L Spitzer; Valerie L Ng; Alden H Harken
Journal:  Surgery       Date:  2007-12-21       Impact factor: 3.982

10.  Incidence and causes of heparin-induced skin lesions.

Authors:  Marc Schindewolf; Svantje Schwaner; Manfred Wolter; Hartmut Kroll; Andreas Recke; Roland Kaufmann; Wolf-Henning Boehncke; Edelgard Lindhoff-Last; Ralf J Ludwig
Journal:  CMAJ       Date:  2009-09-28       Impact factor: 8.262

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.